Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01220414 · ClinicalTrials.gov registry record · NA

Attenuation of Pain in Men and Women

A NA study of Pain, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT01220414: Completed NA study of Pain, sponsored by University of Wisconsin, Madison.

NCT01220414 is a NA study of Pain that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 60 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01220414, a NA study of Pain, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine opioid and endocannabinoid mechanisms of exercise-induced analgesia in men and women.

Conditions Studied

Interventions

  • DRUG Naltrexone, then placebo
  • DRUG Placebo, then Naltrexone

Study Locations (1)

Wisconsin

  • University of Wisconsin-Madison - Madison

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2010-09
Est. Completion 2013-01
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT01220414 record still lists

NCT01220414 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (80% lower).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Naltrexone, then placebo is the first listed.

NCT01220414 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01220414 about?

NCT01220414 is a clinical study titled "Attenuation of Pain in Men and Women". The purpose of this study is to examine opioid and endocannabinoid mechanisms of exercise-induced analgesia in men and women.

What is the current status of trial NCT01220414?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2010-09. Estimated completion is 2013-01.

What conditions does trial NCT01220414 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT01220414?

The interventions under investigation include: Naltrexone, then placebo (DRUG), Placebo, then Naltrexone (DRUG).

Who is sponsoring clinical trial NCT01220414?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01220414 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01220414's enrollment target sits among peer trials

60 224th of 374 higher than 134 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01220414, the US trial registry maintained by the National Library of Medicine. NCT01220414 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.